BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Landuzzi L, Manara MC, Lollini PL, Scotlandi K. Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma. Cells 2021;10:416. [PMID: 33671173 DOI: 10.3390/cells10020416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zou S, Ye M, Zhang JA, Ji H, Chen Y, Zhu X. Establishment and genetically characterization of patient-derived xenograft models of cervical cancer. BMC Med Genomics 2022;15:191. [PMID: 36076209 DOI: 10.1186/s12920-022-01342-5] [Reference Citation Analysis]
2 Solernó LM, Sobol NT, Gottardo MF, Capobianco CS, Ferrero MR, Vásquez L, Alonso DF, Garona J. Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy. Sci Rep 2022;12:15058. [PMID: 36075937 DOI: 10.1038/s41598-022-18324-3] [Reference Citation Analysis]
3 Jiang J, Wang R, Yang L, Sha Y, Zhao S, Guo J, Chen D, Zhong Z, Meng F. IL-11Rα-targeted nanostrategy empowers chemotherapy of relapsed and patient-derived osteosarcoma. J Control Release 2022:S0168-3659(22)00555-7. [PMID: 36041590 DOI: 10.1016/j.jconrel.2022.08.048] [Reference Citation Analysis]
4 Farzaneh M, Najafi S, Anbiyaee O, Azizidoost S, Khoshnam SE. LncRNA MALAT1-related signaling pathways in osteosarcoma. Clin Transl Oncol 2022. [PMID: 35790599 DOI: 10.1007/s12094-022-02876-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang Y, He R, Lei X, Mao L, Yin Z, Zhong X, Cao W, Zheng Q, Li D. Comprehensive Analysis of a Ferroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Landscape in Osteosarcoma. Front Oncol 2022;12:880459. [DOI: 10.3389/fonc.2022.880459] [Reference Citation Analysis]
6 Martella E, Dozza B, Ferroni C, Obeyok CO, Guerrini A, Tedesco D, Manet I, Sotgiu G, Columbaro M, Ballestri M, Martini L, Fini M, Lucarelli E, Varchi G, Duchi S. Two Beats One: Osteosarcoma Therapy with Light-Activated and Chemo-Releasing Keratin Nanoformulation in a Preclinical Mouse Model. Pharmaceutics 2022;14:677. [DOI: 10.3390/pharmaceutics14030677] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Mancarella C, Morrione A, Scotlandi K. Unraveling the IGF System Interactome in Sarcomas Exploits Novel Therapeutic Options. Cells 2021;10:2075. [PMID: 34440844 DOI: 10.3390/cells10082075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cascini C, Chiodoni C. The Immune Landscape of Osteosarcoma: Implications for Prognosis and Treatment Response. Cells 2021;10:1668. [PMID: 34359840 DOI: 10.3390/cells10071668] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
9 Shorokhova M, Nikolsky N, Grinchuk T. Chromothripsis-Explosion in Genetic Science. Cells 2021;10:1102. [PMID: 34064429 DOI: 10.3390/cells10051102] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]